The “DAC” Is Not Just Three Extra Letters
Search CJC-1295 and one comparison appears everywhere:
with DAC vs without DAC.
It is often presented as a simple half-life question.
For research buyers, it is more fundamental than that.
The Drug Affinity Complex (DAC) is part of the molecular design that allows CJC-1295 to interact with circulating albumin and remain active substantially longer than short-acting GHRH-related peptides. Human studies described CJC-1295 as a long-acting GHRH analog capable of producing sustained increases in GH and IGF-I.
So the DAC designation is not merely a product-name suffix.
It helps define the research identity of the molecule.
What Is CJC-1295 with DAC?
CJC-1295 with DAC is a synthetic growth hormone-releasing hormone analog designed for prolonged activity.
SUNONE currently lists:
CAS: 446262-90-4
Molecular Formula: C165H269N47O46
Molecular Weight: approximately 3647.2 g/mol
Purity: ≥98% by HPLC
Form: Lyophilized solid
Grade: Research / HPLC.
Common search terms include CJC-1295 DAC, CJC 1295, DAC:GRF, long-acting GHRH analog and CJC-1295 research peptide.
For professional procurement, however, the important question is:
Does the batch actually match the defined DAC-containing molecule?
Why Albumin Binding Matters
The long duration associated with CJC-1295 comes from its engineered affinity for albumin.
In published human research, CJC-1295 was described as binding to endogenous albumin after administration, with prolonged pharmacokinetic activity and sustained GH/IGF-I responses.
Interestingly, another human study found that natural GH pulsatility was still detectable during the sustained stimulation produced by CJC-1295.
That matters because online discussions often simplify the molecule into:
“DAC means completely flat GH release.”
The human evidence is more nuanced.
“With DAC” and “No DAC” Should Not Be Treated as the Same Research Material
Current Google and forum results frequently use CJC-1295 no DAC and Modified GRF 1-29 almost interchangeably.
That makes exact naming important.
SUNONE separately lists CJC-1295 with DAC and CJC-1295 NO DAC / Modified GRF 1-29 as distinct research products.
For a laboratory buyer, this means a quotation stating only:
“CJC-1295”
may not provide enough analytical information.
The purchase specification should clearly identify whether the material contains the DAC modification.
Positive and Negative Reviews Show the Same Confusion
Current community feedback is highly divided.
Some users report positive subjective experiences and argue that CJC-1295 with DAC is unfairly criticized, particularly because published human studies showed sustained GH/IGF-I responses while preserving aspects of GH pulsatility.
Others report concerns about water retention, facial puffiness or prolonged stimulation and prefer shorter-acting alternatives.
These reports have major limitations:
product identity is often unverified,
other compounds may be used simultaneously,
and the experiences are not controlled clinical evidence.
For research procurement:
online opinion describes perception; analytical data describe the batch.
Why HPLC Purity Alone Is Not Enough
Current 2026 CJC-1295 supplier records increasingly separate several QC questions:
HPLC purity — how clean the principal chromatographic component appears;
Mass-spectrometry identity — whether the observed molecular mass supports CJC-1295 with DAC;
Active content — how much material is present;
Lot traceability — whether the test result belongs to the exact batch being supplied.
This distinction matters particularly for a structurally modified peptide.
A “99% purity” headline cannot by itself prove that the material contains the intended DAC-containing CJC-1295 structure.
FDA Also Highlights Characterization and Safety Questions
FDA currently notes that compounded products containing CJC-1295 may present potential concerns involving peptide impurities, API characterization and immunogenicity for certain routes of administration.
FDA also identifies limited clinical data and reports serious adverse events including increased heart rate and systemic vasodilatory reactions.
This does not mean every research batch has those outcomes.
It does reinforce why professional buyers should focus on identity, impurity control and batch-level documentation rather than broad marketing claims.
SUNONE CJC-1295 with DAC for Research
Sunone (Hong Kong) Biopharmaceutical International Technology Co., Limited supplies CJC-1295 with DAC / CJC-1295 DAC for qualified laboratory, analytical and manufacturing research.
Current SUNONE product information states that batch documentation may include COA, HPLC purity data, mass-spectrometry identity testing and product specification information. Custom synthesis, vial filling, OEM/ODM packaging, labeling and bulk quantities are also available for qualified B2B customers.
View SUNONE CJC-1295 with DAC Specifications：
Looking for a CJC-1295 with DAC Supplier?
For peptide laboratories, biotechnology companies and research distributors, the strongest procurement question is not:
“How long does CJC-1295 last?”
It is:
“Can the supplier verify that the exact batch contains the intended DAC-modified CJC-1295 molecule?”
For organizations sourcing CJC-1295 with DAC, CJC-1295 DAC, DAC:GRF or related GHRH research peptides, SUNONE can provide current specifications, batch documentation, MOQ, packaging and B2B quotation information.
Conclusion
The biggest difference between CJC-1295 with DAC and short-acting GHRH-related peptides is not simply convenience.
It is molecular design.
The DAC modification changes albumin interaction and pharmacokinetic behavior.
“With DAC” and “no DAC” should not be treated as identical research materials.
And HPLC purity alone does not fully establish molecular identity.
For professional sourcing:
verify the exact form, verify identity, verify analytical purity and verify the batch-specific COA.
The long half-life may generate the search.
Molecular clarity should generate the inquiry.
This content is provided for scientific and educational purposes only. SUNONE research peptide is for qualified labrtorynt, diagnois, druc tor mmatct or veteimant, use.research only, Not for human consumption, clinical treame. Purchasers are responsible for complying with applicable laws and regulations in their jurisdiction.
Leave a Reply